DNA TESTING CENTERS CORP (DNAT) financial statements (2020 and earlier)

Company profile

Business Address 2378 PARKHAVEN
OAKVILLE, ON L6H 0E7
State of Incorp. FL
Fiscal Year End December 31
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments478340
Cash and cash equivalents478340
Receivables0   
Prepaid expense0   
Other undisclosed current assets  20
Total current assets:488360
Noncurrent Assets
Property, plant and equipment3345
Total noncurrent assets:3345
TOTAL ASSETS:5087105
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:4033  
Other undisclosed accounts payable and accrued liabilities4033  
Due to related parties150129  
Other undisclosed current liabilities   7
Total current liabilities:189161 7
Noncurrent Liabilities
Other undisclosed liabilities  120 
Total liabilities:1891611207
Stockholders' equity
Stockholders' equity attributable to parent(139)(75)(110)(1)
Common stock2222
Common stock, value, subscriptions100100  
Additional paid in capital206221221169
Accumulated other comprehensive loss(13)(23)(10)(10)
Accumulated deficit(435)(376)(323)(162)
Total stockholders' equity:(139)(75)(110)(1)
TOTAL LIABILITIES AND EQUITY:5087105

Income statement (P&L) ($ in thousands)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues42503221
Cost of revenue
(Cost of Goods and Services Sold)
(22)(29)  
Other undisclosed gross profit  (17) 
Gross profit:20211521
Operating expenses(79)(74)(14)(122)
Other operating expense, net   (101)
Operating income (loss):(59)(53)1(202)
Nonoperating income (expense)
(Foreign Currency Transaction gain, before Tax)
1 1 
Income (loss) before gain (loss) on sale of properties:(58)(53)2(202)
Other undisclosed net income   101
Net income (loss):(58)(53)2(101)
Other undisclosed net loss attributable to parent(1) (163) 
Net loss available to common stockholders, diluted:(59)(53)(161)(101)

Comprehensive Income ($ in thousands)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(58)(53)2(101)
Other comprehensive income (loss)  (161)101
Comprehensive loss:(58)(53)(160)(0)
Comprehensive income, net of tax, attributable to noncontrolling interest   7
Other undisclosed comprehensive income (loss), net of tax, attributable to parent9(13)  
Comprehensive income (loss), net of tax, attributable to parent:(49)(65)(160)7

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: